Developing a risk assessment tool for cancer-related venous thrombosis in China: a modified Delphi-analytic hierarchy process study

To develop a Risk Assessment Tool for Cancer-related Venous Thrombosis in China. A modified two-round Delphi method was employed to establish consensus within a field to reach an agreement via a questionnaire or by interviewing a multidisciplinary panel of experts by collecting their feedback to inf...

Full description

Saved in:
Bibliographic Details
Published in:BMC cancer 2024-01, Vol.24 (1), p.120-8, Article 120
Main Authors: Qin, Xiaoli, Gao, Xiurong, Yang, Yujie, Ou, Shunlong, Luo, Jing, Wei, Hua, Jiang, Qian
Format: Article
Language:English
Subjects:
Analytic Hierarchy Process
Cancer
Cancer-related VTE
Care and treatment
China
Complications and side effects
Delphi method
Diagnosis
Feedback
Health risk assessment
Heart attack
Hierarchies
Humans
Methods
Mortality
Neoplasms
Oncology
Pharmacy
Pulmonary embolisms
Questionnaires
Risk Assessment
Risk assessment tool
Risk factors
Software
Statistical analysis
Stroke (Disease)
Thromboembolism
Thrombosis
Venous thromboembolism
Venous Thrombosis
Citations: Items that this one cites
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:To develop a Risk Assessment Tool for Cancer-related Venous Thrombosis in China. A modified two-round Delphi method was employed to establish consensus within a field to reach an agreement via a questionnaire or by interviewing a multidisciplinary panel of experts by collecting their feedback to inform the next round, exchanging their knowledge, experience, and opinions anonymously, and resolving uncertainties. Furthermore, The AHP (Analytic Hierarchy Process) was used to determine the final quality indicators' relative importance. The expert's positive coefficient was 85.19% in the first round and 82.61% in the second round, with authoritative coefficients of 0.89 and 0.92 in the respective surveys. The P-value of Kendall's W test was all less than 0.001 for each round, and the W-value for concordance at the end of the two rounds was 0.115. The final Risk Assessment Tool for Cancer-related Venous Thrombosis consisted of three domains, ten subdomains, and 39 indicators, with patient factors weighing 0.1976, disease factors weighing 0.4905, and therapeutic factors weighing 0.3119. The tool is significantly valid and reliable with a strong authority and coordination degree, and it can be used to assess the risk of cancer-related VTE and initiate appropriate thrombophylactic interventions in China.
ISSN:1471-2407
1471-2407
DOI:10.1186/s12885-024-11877-8